ARTICLE | Clinical News
BindRen colestilan regulatory update
February 11, 2013 8:00 AM UTC
The European Commission approved BindRen colestilan from Mitsubishi's Mitsubishi Pharma Europe Ltd. subsidiary to treat hyperphosphatemia in adult patients with stage 5 chronic kidney disease (CKD) re...